论文部分内容阅读
摘要目的确定用于预测肝细胞癌(HCC)病人动脉化学栓塞(TACE)和索拉非尼治疗(TACE+索拉非尼)的治疗反应的早期生物标志,并建立有效的预后列线图。材料与方法
Abstract Objective To identify early biomarkers for predicting response to treatment with arterial chemoembolization (TACE) and sorafenib (TACE + sorafenib) in patients with hepatocellular carcinoma (HCC) and to establish an effective prognostic nomogram. Materials and Methods